GLSIHealthcareSmall-Cap
Greenwich LifeSciences, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Greenwich LifeSciences, Inc. (GLSI), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are GLSI insiders buying or selling?
Greenwich LifeSciences, Inc. insiders reported 113 open-market buys ($8.0M) and 0 sells ($0) across 113 Form 4 filings — a net buying position of $8.0M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jan 15, 2026)
Total Form 4 filings
113
SEC EDGAR
Insider filers
6
Insider buys (113)
$8.0M
Insider sells (0)
$0
Insider sentiment
Net buyingNet insider flow of $8.0M in net buying.
Recent GLSI insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 15, 2026 | Snehal Patel | CEO and CFO | Purchase | 1.8K | $29.83 | $53.7K |
| Jan 14, 2026 | Snehal Patel | CEO and CFO | Purchase | 2.9K | $27.54 | $79.9K |
| Jan 5, 2026 | Snehal Patel | CEO and CFO | Purchase | 4.3K | $21.36 | $91.8K |
| Jan 2, 2026 | Snehal Patel | CEO and CFO | Purchase | 2.9K | $21.73 | $63.0K |
| Dec 19, 2025 | Snehal Patel | CEO and CFO | Purchase | 4.1K | $12.62 | $51.7K |
| Nov 28, 2025 | Snehal Patel | CEO and CFO | Purchase | 4.6K | $8.37 | $38.5K |
| Nov 12, 2025 | Snehal Patel | CEO and CFO | Purchase | 10.6K | $8.43 | $89.4K |
| Nov 4, 2025 | Snehal Patel | CEO and CFO | Purchase | 2.3K | $9.26 | $21.3K |
| Apr 29, 2025 | Snehal Patel | CEO and CFO | Purchase | 3.6K | $9.88 | $35.6K |
| Apr 22, 2025 | Snehal Patel | CEO and CFO | Purchase | 5.4K | $8.98 | $48.5K |
| Apr 8, 2025 | Snehal Patel | CEO and CFO | Purchase | 3.6K | $9.10 | $32.8K |
| Apr 7, 2025 | Snehal Patel | CEO and CFO | Purchase | 5.5K | $8.73 | $48.0K |
| Jan 13, 2025 | Snehal Patel | CEO and CFO | Purchase | 2.5K | $12.51 | $31.3K |
| Jan 8, 2025 | Snehal Patel | CEO and CFO | Purchase | 2.9K | $13.58 | $39.4K |
| Jan 7, 2025 | Snehal Patel | CEO and CFO | Purchase | 3.4K | $12.95 | $44.0K |
| Jan 6, 2025 | Snehal Patel | CEO and CFO | Purchase | 2.0K | $11.97 | $23.9K |
| Jan 3, 2025 | Snehal Patel | CEO and CFO | Purchase | 2.4K | $11.36 | $27.3K |
| Jan 2, 2025 | Snehal Patel | CEO and CFO | Purchase | 3.2K | $11.12 | $35.6K |
| Nov 25, 2024 | Jaye Thompson | VP Clinical Reg Affairs | Purchase | 1.0K | $12.91 | $12.9K |
| Sep 30, 2024 | Snehal Patel | CEO and CFO | Purchase | 1.5K | $14.63 | $21.9K |
| Sep 16, 2024 | Jaye Thompson | VP Clinical Reg Affairs | Purchase | 800 | $13.85 | $11.1K |
| Aug 8, 2024 | Snehal Patel | CEO and CFO | Purchase | 2.0K | $13.81 | $27.6K |
| Aug 7, 2024 | Snehal Patel | CEO and CFO | Purchase | 5.5K | $13.18 | $72.5K |
| Aug 5, 2024 | Jaye Thompson | VP Clinical Reg Affairs | Purchase | 1.0K | $15.15 | $15.2K |
| Jul 24, 2024 | Snehal Patel | CEO and CFO | Purchase | 1.5K | $15.89 | $23.8K |
Showing the 25 most recent of 113 Form 4 filings for Greenwich LifeSciences, Inc..
Most active GLSI insiders
- Snehal Patel79 filings
- Jaye Thompson21 filings
- Kenneth Hallock5 filings
- Frank Joseph Daugherty4 filings
- McWilliams David3 filings
Ask anything about GLSI insider activity
Use Trabud's AI agent to query Greenwich LifeSciences, Inc.'s Form 4 history in plain English — "Show me GLSI CEO purchases this year" or compare it against any other ticker.
Open the AI agentGLSI insider trading FAQ
Are Greenwich LifeSciences, Inc. insiders buying or selling?
Across 113 SEC Form 4 filings, Greenwich LifeSciences, Inc. (GLSI) insiders reported 113 open-market purchases totaling $8.0M and 0 sales totaling $0. That is a net buying position of $8.0M.
How many insiders trade GLSI stock?
6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Greenwich LifeSciences, Inc.. The most recent filing was accepted on Jan 15, 2026.
Where does Trabud get GLSI insider trading data?
All GLSI insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.